Pharmaids Pharmaceuticals Limited reported earnings results for the third quarter and nine months ended December 31, 2023. For the third quarter, the company reported sales was INR 0.208 million. Negative revenue was INR 8.8 million. Net loss was INR 16.34 million compared to INR 7.06 million a year ago. Basic loss per share from continuing operations was INR 0.76 compared to INR 0.54 a year ago. Diluted loss per share from continuing operations was INR 0.73 compared to INR 0.5 a year ago.
For the nine months, sales was INR 0.208 million. Negative revenue was INR 7.66 million. Net loss was INR 34.39 million compared to INR 13.94 million a year ago. Basic loss per share from continuing operations was INR 1.6 compared to INR 1.07 a year ago. Diluted loss per share from continuing operations was INR 1.54 compared to INR 1 a year ago.